These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2501896

  • 21. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E, Furlan M, Barbieri B, Donati MB, Beck EA.
    Thromb Haemost; 1984 Aug 31; 52(1):57-9. PubMed ID: 6437011
    [Abstract] [Full Text] [Related]

  • 22. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I, Farrugia A, Tran E, Anastasius V, Charnock A.
    Biologicals; 1998 Jun 31; 26(2):155-66. PubMed ID: 9811523
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL.
    J Lab Clin Med; 1984 Nov 31; 104(5):816-28. PubMed ID: 6436416
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
    Foster PR, Griffin BD, Bienek C, McIntosh RV, MacGregor IR, Somerville RA, Steele PJ, Reichl HE.
    Vox Sang; 2004 Feb 31; 86(2):92-9. PubMed ID: 15023177
    [Abstract] [Full Text] [Related]

  • 29. Factor VIII concentrate: what is "high purity"?
    Schoppmann A, Weber A, Hondl F, Linnau Y.
    Thromb Haemost; 1994 Sep 31; 72(3):483-4. PubMed ID: 7855803
    [No Abstract] [Full Text] [Related]

  • 30. Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg.
    Nordfang O, Ezban M, Dinesen B.
    Thromb Haemost; 1985 Jun 24; 53(3):346-50. PubMed ID: 3931283
    [Abstract] [Full Text] [Related]

  • 31. Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma.
    Rock G, Palmer DS.
    Thromb Haemost; 1985 Dec 17; 54(4):780-3. PubMed ID: 3937275
    [Abstract] [Full Text] [Related]

  • 32. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
    Mori F, Nardini I, Rossi P, Nardini C, Farina C.
    Vox Sang; 2008 Nov 17; 95(4):298-307. PubMed ID: 19138259
    [Abstract] [Full Text] [Related]

  • 33. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M, Perret BA, Beck EA.
    Schweiz Med Wochenschr; 1980 Oct 04; 110(40):1456-8. PubMed ID: 6792697
    [Abstract] [Full Text] [Related]

  • 34. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
    Schwinn H, Smith A, Wolter D.
    Arzneimittelforschung; 1989 Oct 04; 39(10):1302-5. PubMed ID: 2514695
    [Abstract] [Full Text] [Related]

  • 35. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L, Mannucci PM, Federici AB, Coppola R, Guzzoni S, Agostoni A.
    J Lab Clin Med; 1995 Mar 04; 125(3):348-55. PubMed ID: 7897302
    [Abstract] [Full Text] [Related]

  • 36. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO, Sanders JC, Eyster ME.
    Thromb Haemost; 1981 Feb 23; 45(1):68-72. PubMed ID: 6166064
    [Abstract] [Full Text] [Related]

  • 37. Extracorporeal protein A-sepharose and specific affinity chromatography for removal of antibodies.
    Nilsson IM, Sundqvist SB, Freiburghaus C.
    Prog Clin Biol Res; 1984 Feb 23; 150():225-41. PubMed ID: 6431430
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP, Pietu G, Lavergne JM, Meyer D, Larrieu MJ.
    J Lab Clin Med; 1982 Apr 23; 99(4):481-94. PubMed ID: 6174657
    [Abstract] [Full Text] [Related]

  • 40. Definition of the affinity of binding between human von Willebrand factor and coagulation factor VIII.
    Ganz PR, Atkins JS, Palmer DS, Dudani AK, Hashemi S, Luison F.
    Biochem Biophys Res Commun; 1991 Oct 15; 180(1):231-7. PubMed ID: 1930219
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.